BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni H, Yang M, Guo Z, Zhang T. Sorafenib combined with cryoablation to treat unresectable hepatocellular carcinoma. Chin J Cancer Res 2011;23:188-93. [PMID: 23467380 DOI: 10.1007/s11670-011-0188-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Chi Y, Yang J, Yang S, Sun Y, Jia B, Shi Y. Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer. Chin J Cancer Res 2015;27:239-46. [PMID: 26157320 DOI: 10.3978/j.issn.1000-9604.2015.06.08] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Liu C, Cao F, Xing W, Si T, Yu H, Yang X, Guo Z. Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma. International Journal of Hyperthermia 2019;36:219-27. [DOI: 10.1080/02656736.2018.1556819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]